This case describes the successful use of CytoSorb with CRRT and extracorporeal life support in a combined way to overcome a critical phase of septic shock.
89
Cardiovascular
Dr. Henriette Roed-Undlien
Norway, Oslo
In this in vitro study, apixaban levels were effectively reduced, and the clotting time and thrombin generation assays were normalized by the use of CytoSorb.
89
95
Cardiovascular
Certified Clinical Perfusionist Martin Clerici
Argentina, Buenos Aires
Intraoperative use of CytoSorb® in an endocarditis patient with extensive cardiovascular history was associated with improvements in the hemodynamic situation.